Healthcare

Global Cancer Targeted Therapy Market Analysis By Type, Application, Regions and Companies Forecast 2016-2027

Report Format PDF, PPT, Excel
No. of Pages 103
The latest study on Cancer Targeted Therapy Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global XXX Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Cancer Targeted Therapy and is a must have data for all the companies, investors, decision makers, top level executives and readers. The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027. The major vendors covered: Advaxis Bind Therapeutics Boehringer Ingelheim Bristol Mayer Squibb Celldex Therapeutics Dendreon Corporation Eli Lily GalaxoSmithKline Galena Biopharma Genetech ImmunoCellular Therapeutics ImmunoGen Inovio Pharmaceuticals Johnson & Johnson NeoStem Oncology NewLink Genetics Northwest Biotherapeutics Merck Novartis Peregrine Pharmaceuticals Pfizer Roche Sanofi Seattle Genetics Teva Cancer Targeted Therapy Market Analysis By Type Segment: Tumor Antigens As Targets of Antibodies Development of Antibodies for Clinical Purposes Complement Dependent Cytotoxicity (CDC) Signal Transduction Changes Cancer Targeted Therapy Market Analysis By Application Segment: Hospital Clinic Other Cancer Targeted Therapy Market Analysis By Regions (Countries):- The Cancer Targeted Therapy Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions. Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions. Key Details of Regions and Countries of Cancer Targeted Therapy Report: United States Europe China Japan Southeast Asia India Central & South America Key data provided: Market Size of Regions Market Share of Regions Compound Annual Growth Rate (CAGR) Historic Data From 2016-2020 Forecast Data From 2021-2027 Competitive Landscape of Cancer Targeted Therapy Market: Cancer Targeted Therapy market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market. Key Questions Answered in Competitive Landscape- List of Key Players Revenue By players Market share of players Product Offerings The study objectives are: To analyze and research the Cancer Targeted Therapy Market status and future forecast. To present the key Cancer Targeted Therapy Market analysis of companies and present revenue, market share, and recent development for key players. To split the breakdown data by regions, type, companies and applications To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends, drivers, influence factors in global and regions To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Cancer Targeted Therapy Market Size Growth Rate by Type (2016-2027) 1.4.2 Tumor Antigens As Targets of Antibodies 1.4.3 Development of Antibodies for Clinical Purposes 1.4.4 Complement Dependent Cytotoxicity (CDC) 1.4.5 Signal Transduction Changes 1.5 Market by Application 1.5.1 Global Cancer Targeted Therapy Market Share by Application (2016-2027) 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Cancer Targeted Therapy Market Size 2.2 Cancer Targeted Therapy Growth Trends by Regions 2.2.1 Cancer Targeted Therapy Market Size by Regions (2016-2027) 2.2.2 Cancer Targeted Therapy Market Share by Regions (2016-2020) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Cancer Targeted Therapy Market Size by Manufacturers 3.1.1 Global Cancer Targeted Therapy Revenue by Manufacturers (2016-2020) 3.1.2 Global Cancer Targeted Therapy Revenue Market Share by Manufacturers (2016-2020) 3.1.3 Global Cancer Targeted Therapy Market Concentration Ratio (CR5 and HHI) 3.2 Cancer Targeted Therapy Key Players Head office and Area Served 3.3 Key Players Cancer Targeted Therapy Product/Solution/Service 3.4 Date of Enter into Cancer Targeted Therapy Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Cancer Targeted Therapy Market Size by Type (2016-2020) 4.2 Global Cancer Targeted Therapy Market Size by Application (2016-2020) 5 United States 5.1 United States Cancer Targeted Therapy Market Size (2016-2020) 5.2 Cancer Targeted Therapy Key Players in United States 5.3 United States Cancer Targeted Therapy Market Size by Type 5.4 United States Cancer Targeted Therapy Market Size by Application 6 Europe 6.1 Europe Cancer Targeted Therapy Market Size (2016-2020) 6.2 Cancer Targeted Therapy Key Players in Europe 6.3 Europe Cancer Targeted Therapy Market Size by Type 6.4 Europe Cancer Targeted Therapy Market Size by Application 7 China 7.1 China Cancer Targeted Therapy Market Size (2016-2020) 7.2 Cancer Targeted Therapy Key Players in China 7.3 China Cancer Targeted Therapy Market Size by Type 7.4 China Cancer Targeted Therapy Market Size by Application 8 Japan 8.1 Japan Cancer Targeted Therapy Market Size (2016-2020) 8.2 Cancer Targeted Therapy Key Players in Japan 8.3 Japan Cancer Targeted Therapy Market Size by Type 8.4 Japan Cancer Targeted Therapy Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Cancer Targeted Therapy Market Size (2016-2020) 9.2 Cancer Targeted Therapy Key Players in Southeast Asia 9.3 Southeast Asia Cancer Targeted Therapy Market Size by Type 9.4 Southeast Asia Cancer Targeted Therapy Market Size by Application 10 India 10.1 India Cancer Targeted Therapy Market Size (2016-2020) 10.2 Cancer Targeted Therapy Key Players in India 10.3 India Cancer Targeted Therapy Market Size by Type 10.4 India Cancer Targeted Therapy Market Size by Application 11 Central & South America 11.1 Central & South America Cancer Targeted Therapy Market Size (2016-2020) 11.2 Cancer Targeted Therapy Key Players in Central & South America 11.3 Central & South America Cancer Targeted Therapy Market Size by Type 11.4 Central & South America Cancer Targeted Therapy Market Size by Application 12 International Players Profiles 12.1 Advaxis 12.1.1 Advaxis Company Details 12.1.2 Company Description and Business Overview 12.1.3 Cancer Targeted Therapy Introduction 12.1.4 Advaxis Revenue in Cancer Targeted Therapy Business (2016-2020) 12.1.5 Advaxis Recent Development 12.2 Bind Therapeutics 12.2.1 Bind Therapeutics Company Details 12.2.2 Company Description and Business Overview 12.2.3 Cancer Targeted Therapy Introduction 12.2.4 Bind Therapeutics Revenue in Cancer Targeted Therapy Business (2016-2020) 12.2.5 Bind Therapeutics Recent Development 12.3 Boehringer Ingelheim 12.3.1 Boehringer Ingelheim Company Details 12.3.2 Company Description and Business Overview 12.3.3 Cancer Targeted Therapy Introduction 12.3.4 Boehringer Ingelheim Revenue in Cancer Targeted Therapy Business (2016-2020) 12.3.5 Boehringer Ingelheim Recent Development 12.4 Bristol Mayer Squibb 12.4.1 Bristol Mayer Squibb Company Details 12.4.2 Company Description and Business Overview 12.4.3 Cancer Targeted Therapy Introduction 12.4.4 Bristol Mayer Squibb Revenue in Cancer Targeted Therapy Business (2016-2020) 12.4.5 Bristol Mayer Squibb Recent Development 12.5 Celldex Therapeutics 12.5.1 Celldex Therapeutics Company Details 12.5.2 Company Description and Business Overview 12.5.3 Cancer Targeted Therapy Introduction 12.5.4 Celldex Therapeutics Revenue in Cancer Targeted Therapy Business (2016-2020) 12.5.5 Celldex Therapeutics Recent Development 12.6 Dendreon Corporation 12.6.1 Dendreon Corporation Company Details 12.6.2 Company Description and Business Overview 12.6.3 Cancer Targeted Therapy Introduction 12.6.4 Dendreon Corporation Revenue in Cancer Targeted Therapy Business (2016-2020) 12.6.5 Dendreon Corporation Recent Development 12.7 Eli Lily 12.7.1 Eli Lily Company Details 12.7.2 Company Description and Business Overview 12.7.3 Cancer Targeted Therapy Introduction 12.7.4 Eli Lily Revenue in Cancer Targeted Therapy Business (2016-2020) 12.7.5 Eli Lily Recent Development 12.8 GalaxoSmithKline 12.8.1 GalaxoSmithKline Company Details 12.8.2 Company Description and Business Overview 12.8.3 Cancer Targeted Therapy Introduction 12.8.4 GalaxoSmithKline Revenue in Cancer Targeted Therapy Business (2016-2020) 12.8.5 GalaxoSmithKline Recent Development 12.9 Galena Biopharma 12.9.1 Galena Biopharma Company Details 12.9.2 Company Description and Business Overview 12.9.3 Cancer Targeted Therapy Introduction 12.9.4 Galena Biopharma Revenue in Cancer Targeted Therapy Business (2016-2020) 12.9.5 Galena Biopharma Recent Development 12.10 Genetech 12.10.1 Genetech Company Details 12.10.2 Company Description and Business Overview 12.10.3 Cancer Targeted Therapy Introduction 12.10.4 Genetech Revenue in Cancer Targeted Therapy Business (2016-2020) 12.10.5 Genetech Recent Development 12.11 ImmunoCellular Therapeutics 12.12 ImmunoGen 12.13 Inovio Pharmaceuticals 12.14 Johnson & Johnson 12.15 NeoStem Oncology 12.16 NewLink Genetics 12.17 Northwest Biotherapeutics 12.18 Merck 12.19 Novartis 12.20 Peregrine Pharmaceuticals 12.21 Pfizer 12.22 Roche 12.23 Sanofi 12.24 Seattle Genetics 12.25 Teva 13 Market Forecast 2021-2027 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2021-2027) 13.10 Market Size Forecast by Application (2021-2027) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures

List of Tables and Figures Table Cancer Targeted Therapy Key Market Segments Table Key Players Cancer Targeted Therapy Covered Table Global Cancer Targeted Therapy Market Size Growth Rate by Type 2016-2027 (Million US$) Figure Global Cancer Targeted Therapy Market Size Market Share by Type 2016-2027 Figure Tumor Antigens As Targets of Antibodies Figures Table Key Players of Tumor Antigens As Targets of Antibodies Figure Development of Antibodies for Clinical Purposes Figures Table Key Players of Development of Antibodies for Clinical Purposes Figure Complement Dependent Cytotoxicity (CDC) Figures Table Key Players of Complement Dependent Cytotoxicity (CDC) Figure Signal Transduction Changes Figures Table Key Players of Signal Transduction Changes Table Global Cancer Targeted Therapy Market Size Growth by Application 2016-2027 (Million US$) Figure Hospital Case Studies Figure Clinic Case Studies Figure Other Case Studies Figure Cancer Targeted Therapy Report Years Considered Table Global Cancer Targeted Therapy Market Size 2016-2027 (Million US$) Figure Global Cancer Targeted Therapy Market Size and Growth Rate 2016-2027 (Million US$) Table Global Cancer Targeted Therapy Market Size by Regions 2016-2027 (Million US$) Table Global Cancer Targeted Therapy Market Size by Regions 2016-2020 (Million US$) Table Global Cancer Targeted Therapy Market Share by Regions 2016-2020 Figure Global Cancer Targeted Therapy Market Share by Regions 2016-2020 Figure Global Cancer Targeted Therapy Market Share by Regions 2019 Table Market Top Trends Table Global Cancer Targeted Therapy Revenue by Manufacturers (2019-2020) (Million US$) Table Global Cancer Targeted Therapy Market Share by Manufacturers (2019-2020) Figure Global Cancer Targeted Therapy Market Share by Manufacturers in 2020 Table Global Cancer Targeted Therapy Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Cancer Targeted Therapy Product/Solution/Service Table Date of Enter into Cancer Targeted Therapy Market Table Mergers & Acquisitions, Expansion Plans Table Global Cancer Targeted Therapy Market Size by Type (2016-2020) (Million US$) Table Global Cancer Targeted Therapy Market Size Share by Type (2016-2020) Figure Global Cancer Targeted Therapy Market Size Market Share by Type (2016-2020) Table Global Cancer Targeted Therapy Market Size by Application (2016-2020) (Million US$) Table Global Cancer Targeted Therapy Market Size Share by Application (2016-2020) Figure Global Cancer Targeted Therapy Market Size Market Share by Application (2016-2020) Figure Global Cancer Targeted Therapy Revenue Market Share by Application in 2020 Figure United States Cancer Targeted Therapy Market Size 2016-2020 (Million US$) Table United States Key Players Cancer Targeted Therapy Revenue (2019-2020) (Million US$) Table United States Key Players Cancer Targeted Therapy Market Share (2019-2020) Table United States Cancer Targeted Therapy Market Size by Type (2016-2020) (Million US$) Table United States Cancer Targeted Therapy Market Share by Type (2016-2020) Table United States Cancer Targeted Therapy Market Size by Application (2016-2020) (Million US$) Table United States Cancer Targeted Therapy Market Share by Application (2016-2020) Figure Europe Cancer Targeted Therapy Market Size 2016-2020 (Million US$) Table Europe Key Players Cancer Targeted Therapy Revenue (2019-2020) (Million US$) Table Europe Key Players Cancer Targeted Therapy Market Share (2019-2020) Table Europe Cancer Targeted Therapy Market Size by Type (2016-2020) (Million US$) Table Europe Cancer Targeted Therapy Market Share by Type (2016-2020) Table Europe Cancer Targeted Therapy Market Size by Application (2016-2020) (Million US$) Table Europe Cancer Targeted Therapy Market Share by Application (2016-2020) Figure China Cancer Targeted Therapy Market Size 2016-2020 (Million US$) Table China Key Players Cancer Targeted Therapy Revenue (2019-2020) (Million US$) Table China Key Players Cancer Targeted Therapy Market Share (2019-2020) Table China Cancer Targeted Therapy Market Size by Type (2016-2020) (Million US$) Table China Cancer Targeted Therapy Market Share by Type (2016-2020) Table China Cancer Targeted Therapy Market Size by Application (2016-2020) (Million US$) Table China Cancer Targeted Therapy Market Share by Application (2016-2020) Figure Japan Cancer Targeted Therapy Market Size 2016-2020 (Million US$) Table Japan Key Players Cancer Targeted Therapy Revenue (2019-2020) (Million US$) Table Japan Key Players Cancer Targeted Therapy Market Share (2019-2020) Table Japan Cancer Targeted Therapy Market Size by Type (2016-2020) (Million US$) Table Japan Cancer Targeted Therapy Market Share by Type (2016-2020) Table Japan Cancer Targeted Therapy Market Size by Application (2016-2020) (Million US$) Table Japan Cancer Targeted Therapy Market Share by Application (2016-2020) Figure Southeast Asia Cancer Targeted Therapy Market Size 2016-2020 (Million US$) Table Southeast Asia Key Players Cancer Targeted Therapy Revenue (2019-2020) (Million US$) Table Southeast Asia Key Players Cancer Targeted Therapy Market Share (2019-2020) Table Southeast Asia Cancer Targeted Therapy Market Size by Type (2016-2020) (Million US$) Table Southeast Asia Cancer Targeted Therapy Market Share by Type (2016-2020) Table Southeast Asia Cancer Targeted Therapy Market Size by Application (2016-2020) (Million US$) Table Southeast Asia Cancer Targeted Therapy Market Share by Application (2016-2020) Figure India Cancer Targeted Therapy Market Size 2016-2020 (Million US$) Table India Key Players Cancer Targeted Therapy Revenue (2019-2020) (Million US$) Table India Key Players Cancer Targeted Therapy Market Share (2019-2020) Table India Cancer Targeted Therapy Market Size by Type (2016-2020) (Million US$) Table India Cancer Targeted Therapy Market Share by Type (2016-2020) Table India Cancer Targeted Therapy Market Size by Application (2016-2020) (Million US$) Table India Cancer Targeted Therapy Market Share by Application (2016-2020) Figure Central & South America Cancer Targeted Therapy Market Size 2016-2020 (Million US$) Table Central & South America Key Players Cancer Targeted Therapy Revenue (2019-2020) (Million US$) Table Central & South America Key Players Cancer Targeted Therapy Market Share (2019-2020) Table Central & South America Cancer Targeted Therapy Market Size by Type (2016-2020) (Million US$) Table Central & South America Cancer Targeted Therapy Market Share by Type (2016-2020) Table Central & South America Cancer Targeted Therapy Market Size by Application (2016-2020) (Million US$) Table Central & South America Cancer Targeted Therapy Market Share by Application (2016-2020) Table Advaxis Company Details Table Advaxis Revenue in Cancer Targeted Therapy Business (2016-2020) (Million US$) Figure Advaxis Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table Advaxis Recent Development Table Bind Therapeutics Company Details Table Bind Therapeutics Revenue in Cancer Targeted Therapy Business (2016-2020)(Million US$) Figure Bind Therapeutics Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table Bind Therapeutics Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Revenue in Cancer Targeted Therapy Business (2016-2020)(Million US$) Figure Boehringer Ingelheim Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table Boehringer Ingelheim Recent Development Table Bristol Mayer Squibb Company Details Table Bristol Mayer Squibb Revenue in Cancer Targeted Therapy Business (2016-2020)(Million US$) Figure Bristol Mayer Squibb Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table Bristol Mayer Squibb Recent Development Table Celldex Therapeutics Company Details Table Celldex Therapeutics Revenue in Cancer Targeted Therapy Business (2016-2020)(Million US$) Figure Celldex Therapeutics Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table Celldex Therapeutics Recent Development Table Dendreon Corporation Company Details Table Dendreon Corporation Revenue in Cancer Targeted Therapy Business (2016-2020)(Million US$) Figure Dendreon Corporation Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table Dendreon Corporation Recent Development Table Eli Lily Company Details Table Eli Lily Revenue in Cancer Targeted Therapy Business (2016-2020)(Million US$) Figure Eli Lily Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table Eli Lily Recent Development Table GalaxoSmithKline Company Details Table GalaxoSmithKline Revenue in Cancer Targeted Therapy Business (2016-2020)(Million US$) Figure GalaxoSmithKline Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table GalaxoSmithKline Recent Development Table Galena Biopharma Company Details Table Galena Biopharma Revenue in Cancer Targeted Therapy Business (2016-2020)(Million US$) Figure Galena Biopharma Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table Galena Biopharma Recent Development Table Genetech Company Details Table Genetech Revenue in Cancer Targeted Therapy Business (2016-2020)(Million US$) Figure Genetech Revenue Growth Rate in Cancer Targeted Therapy Business (2016-2020) Table Genetech Recent Development Table ImmunoCellular Therapeutics Company Details Table ImmunoGen Company Details Table Inovio Pharmaceuticals Company Details Table Johnson & Johnson Company Details Table NeoStem Oncology Company Details Table NewLink Genetics Company Details Table Northwest Biotherapeutics Company Details Table Merck Company Details Table Novartis Company Details Table Peregrine Pharmaceuticals Company Details Table Pfizer Company Details Table Roche Company Details Table Sanofi Company Details Table Seattle Genetics Company Details Table Teva Company Details Table Global Cancer Targeted Therapy Market Size by Regions (Million US$) 2021-2027 Figure Global Cancer Targeted Therapy Market Size Share by Regions (2021-2027) Figure Global Cancer Targeted Therapy Market Size Share by Regions in 2027 Figure United States Cancer Targeted Therapy Market Size Forecast (2021-2027)(Million USD) Figure Europe Cancer Targeted Therapy Market Size Forecast (2021-2027)(Million USD) Figure China Cancer Targeted Therapy Market Size Forecast (2021-2027)(Million USD) Figure Japan Cancer Targeted Therapy Market Size Forecast (2021-2027)(Million USD) Figure Southeast Asia Cancer Targeted Therapy Market Size Forecast (2021-2027)(Million USD) Figure India Cancer Targeted Therapy Market Size Forecast (2021-2027)(Million USD) Figure Central & South America Cancer Targeted Therapy Market Size Forecast (2021-2027)(Million USD) Table Global Cancer Targeted Therapy Market Size by Product (2021-2027) (Million US$) Figure Global Cancer Targeted Therapy Market Size by Product (2021-2027) Figure Global Cancer Targeted Therapy Market Size by Product in 2027 Table Global Cancer Targeted Therapy Market Size by Application (2021-2027) (Million US$) Figure Global Cancer Targeted Therapy Market Size by Application (2021-2027) Figure Global Cancer Targeted Therapy Market Size by Application in 2027 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Have questions about this research?

Speak directly with our analysts for custom insights

Contact Analyst
Starting From
$3500
$3500
$7000

Purchase Includes

PDF Report Comprehensive market analysis
PPT Presentation Executive summary slides
Excel Data Pack Market data & statistics
Analyst Support 10 hours of expert guidance
Free Updates 12 months data updates
Customization Up to 40 hours included

Have Any Questions?

Need a sample copy or have questions about pricing? Our team is here to help.

+1 646 583 1932